When all pharmaceutical companies are spending less, should the focus be to get them to spend more or should it be to get more clients?
I think that with each client having a limited pot, probably the most effective way for agencies to stay on track or increase profits is to win more business i.e. several small pots = one big pot. Another strategy would be to diversify your offering i.e. greater access to more pots.
I have not forgotten the costs inherent in pitching for new business or in creating a broader offering. However, could these costs in the short-term not be more effective in generating profit than trying to cajole clients to spend money they don't have?
No comments:
Post a Comment